Facebooktwitterredditlinkedinmail
Diabetes Bites Newsletter

TRIVIA TIME!


Last month, we asked HOW MANY STATE MEDICAID PROGRAMS (out of 50) COVER CGM FOR PEOPLE WITH TYPE-1

Answer:  14 states.  For those doing the math, that equates to just 28% of states in the U.S.

Congratulations to Jenn Velez, a pump, CGM, and soon-to-be-hybrid-closed-loop user from Wallkill, NY. Jenn was the first person to provide the correct answer.

NEW QUESTION for MARCH:

trivia question - drug sales

It seems that the top-selling insulin in 2019 was Sanofi’s Lantus (glargine), with $4.1 billion in sales.  Humalog (lispro) and Novolog (aspart) were 2nd and 3rd, with $3.0B and 2.8B in sales respectively.

But the #1 diabetes medication generated just over $5.5 billion in sales last year.  What was it?

Email Your Response

*The first person to submit the correct answer wins their choice of book from our in-store or online bookstore.